A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer
Clinical trial NCT07137390 · WITHDRAWN
Trial details
- NCT number
- NCT07137390
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-03
- Primary completion
- 2026-01-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.